---
title: "MADRIGAL PHARMACEUTICALS UK LIMITED — Ownership Dossier"
canonical: https://whiteintel.dev/entity/8704fc13-344f-5b55-b520-e3d6cfc52807
json: https://whiteintel.dev/api/public/dossier/8704fc13-344f-5b55-b520-e3d6cfc52807
identifier: oo:GB-COH-05539649
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# MADRIGAL PHARMACEUTICALS UK LIMITED

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-05539649`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/8704fc13-344f-5b55-b520-e3d6cfc52807  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/8704fc13-344f-5b55-b520-e3d6cfc52807  

## Ownership & control

### Owners / controllers

- **Madrigal Pharmaceuticals, Inc.** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/bc6b9124-904c-4162-bf6a-eadc72a27af7

### UBO chain (walk to the ultimate owner)

A **1-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `05539649`
- **Status:** active
- **Type:** ltd
- **Incorporated:** 2005-08-18
- **Registered office:** C/O Fora 20 Eastbourne Terrace, Paddington, London, W2 6LG, United Kingdom
- **SIC:** 46460

### Officers

- [CITCO MANAGEMENT (UK) LIMITED](https://whiteintel.dev/entity/ab77624d-486e-58ba-bdeb-ab56012479d0) — corporate secretary · appointed 2026-02-27
- COX, Paul Astley — director · British · appointed 2025-07-01
- DUSORUTH, Devun — director · British · appointed 2025-07-01
- NOISEL, Pauline Marie Anne Louise — director · French · appointed 2026-07-24
- MADRIGAL PHARMACEUTICALS, INC — corporate director · appointed 2005-08-18
- ALPHA SECRETARIAL LIMITED — corporate nominee secretary · appointed 2005-08-18 · resigned 2005-08-18
- [F W STEPHENS (SECRETARIAL) LIMITED](https://whiteintel.dev/entity/739fd230-c829-511d-bfae-69cef9eb2bcd) — corporate secretary · appointed 2005-08-18 · resigned 2026-02-27
- DRINKWINE, Justin — director · American · appointed 2024-10-29 · resigned 2026-07-24
- EHRLICH, Keith — director · American · appointed 2011-12-15 · resigned 2015-02-19
- JACOBSON, Eric — director · United States · appointed 2008-10-01 · resigned 2009-09-08
- SCHNEEBAUM, Marc — director · American · appointed 2015-02-19 · resigned 2021-06-30
- VUKOVIC, Vojislav — director · Canadian · appointed 2009-09-08 · resigned 2015-03-11
- ALPHA DIRECT LIMITED — corporate nominee director · appointed 2005-08-18 · resigned 2005-08-18

### Beneficial owners (Persons with Significant Control)

- [Madrigal Pharmaceuticals, Inc.](https://whiteintel.dev/entity/bc6b9124-904c-4162-bf6a-eadc72a27af7) — 75–100% shares · corporate PSC · United States — since 2024-10-29

## Provenance

- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/05539649
- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/05539649

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **MADRIGAL PHARMACEUTICALS UK LIMITED**. Human view: https://whiteintel.dev/entity/8704fc13-344f-5b55-b520-e3d6cfc52807 · Structured JSON: https://whiteintel.dev/api/public/dossier/8704fc13-344f-5b55-b520-e3d6cfc52807._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._